FDA.reportPublic FDA data

NDC 60505-6152-04 - Ceftriaxone Sodium

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
60505-6152
Requested NDC
60505-6152-04
Package NDCs from labels
60505-6152-4, 60505-6152-1, 60505-6152-04
Manufacturer
Sportpharm LLC | ASCLEMED USA INC. DBA ENOVACHEM
Effective date
2026-04-24
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Ceftriaxone Sodium - Sportpharm LLC | ASCLEMED USA INC. DBA ENOVACHEMSportpharm LLC | ASCLEMED USA INC. DBA ENOVACHEM2026-04-24HUMAN PRESCRIPTION DRUG LABEL
Ceftriaxone Sodium - A-S Medication SolutionsA-S Medication Solutions2024-08-20HUMAN PRESCRIPTION DRUG LABEL
Ceftriaxone for Injection, USPREMEDYREPACK INC.2024-04-03HUMAN PRESCRIPTION DRUG LABEL
Ceftriaxone Sodium - Proficient Rx LPProficient Rx LP2024-02-01HUMAN PRESCRIPTION DRUG LABEL
Ceftriaxone Sodium - Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEMAsclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM2023-09-02HUMAN PRESCRIPTION DRUG LABEL
Ceftriaxone for Injection, USPApotex Corp. | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd.(High Tech Zone Site) | Qilu Antibiotics Pharmaceutical Co., Ltd.2023-08-31HUMAN PRESCRIPTION DRUG LABEL
Ceftriaxone Sodium - A-S Medication SolutionsA-S Medication Solutions2020-05-29HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
60505-6152-1Ceftriaxone Sodium1 in 1 VIAL, SINGLE-USEINJECTION, POWDER, FOR SOLUTION111
60505-6152-1Ceftriaxone Sodium10 in 1 CARTONINJECTION, POWDER, FOR SOLUTION1011
60505-6152-4Ceftriaxone Sodium1 in 1 CARTONINJECTION, POWDER, FOR SOLUTION111
60505-6152-4Ceftriaxone Sodium1 in 1 VIAL, SINGLE-USEINJECTION, POWDER, FOR SOLUTION111

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60505-6152CEFTRIAXONE SODIUM INJECTION, POWDER, FOR SOLUTION [APOTEX CORP.]11Current NDC, Legacy NDC, 4 package rows20230831_5116231f-82d1-44be-b08e-560c9a50e5c5.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
60505-6152-1EA - Each60505-6152bd13c170-47ed-418c-8d90-899a398ed6ab12017-07-07
60505-6152-4EA - Each60505-6152943a5c92-d054-40ec-8f8b-2961d85c6ca512017-07-07

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 37 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Ceftriaxone SodiumCEFTRIAXONE SODIUMSportpharm LLCddbc3bf6-5bab-4851-ae5a-ef263cd8f2552026-07-23Warnings, Adverse reactionsExact identifier
rxcui: 1665005
rxcui: 309092
rxcui: 1665021
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONEWG Critical Care, LLC86ec0a92-a552-4a6d-9125-a54f95e433922026-06-18Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMSportpharm LLC85ce4f8b-77e0-48bf-9f57-93f1478befa22026-04-24Warnings, Adverse reactionsExact identifier
application number: ANDA203702
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMSportpharm LLC9a937e47-8c36-4656-83e1-b3c18ed9bac32026-04-24Warnings, Adverse reactionsExact identifier
application number: ANDA203702
ndc (package): 85766-128-10
ndc (package): 85766-128-01
ndc (product): 85766-128
rxcui: 1665005
spl id: 50323753-188c-7c42-e063-6294a90ac31b
spl set id: 9a937e47-8c36-4656-83e1-b3c18ed9bac3
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMREMEDYREPACK INC.9c801096-ca61-4b29-a1e1-5f7e7813b1912026-02-06Warnings, Adverse reactionsExact identifier
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMQilu Pharmaceutical Co., Ltd.4cdf0743-c62b-4969-b9c9-4c6400644f6c2026-02-04Warnings, Adverse reactionsExact identifier
application number: ANDA203702
rxcui: 1665046
rxcui: 1665005
rxcui: 309092
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMHospira, Inc128bb292-d174-4769-b3e6-9f16617f31e32026-01-22Warnings, Adverse reactionsExact identifier
rxcui: 1665046
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMHospira, Inc19141ccd-e66c-49a2-a794-0616028495a72026-01-19Warnings, Adverse reactionsExact identifier
rxcui: 1665046
rxcui: 1665005
rxcui: 309092
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMHospira, Inc03283208-8616-4117-9d2b-aa8046017a4f2026-01-19Warnings, Adverse reactionsExact identifier
rxcui: 1665046
rxcui: 1665005
rxcui: 309092
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMHospira, Inc365fc265-8e6c-432f-9fda-911f5f7fb4512026-01-16Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMHospira, Inc36c07ebf-b091-483e-b2c4-f0fc0c2b41862026-01-16Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONEWG Critical Care, LLC7bed9b33-29e3-4f04-9766-43a21c7ad47a2026-01-07Warnings, Adverse reactionsExact identifier
rxcui: 1665046
rxcui: 1665021
unii: 023Z5BR09K
3bdbf8ad-3e73-5be7-e063-6394a90ac385a8d3ffc3-84cf-4a5a-957f-b31f8ae32ed42025-08-08Warnings, Adverse reactionsExact identifier
spl set id: a8d3ffc3-84cf-4a5a-957f-b31f8ae32ed4
CeftriaxoneCEFTRIAXONEWG Critical Care, LLCbefd73ff-cb3b-4543-8a8e-bdb9b7fc1ff02025-04-07Warnings, Adverse reactionsExact identifier
rxcui: 1665046
rxcui: 1665005
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMSandoz Inc53df951b-2eee-44b1-bae2-df7ed85bc0ed2025-02-28Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMSandoz Incde028434-46cf-44f6-8ac6-889c7c6943b32025-02-27Warnings, Adverse reactionsExact identifier
rxcui: 1665046
rxcui: 1665005
rxcui: 309092
rxcui: 1665021
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONE SODIUMBaxter Healthcare Company4c5c2d3f-5038-41a1-a2fe-4dcd048dbac12024-10-07Warnings, Adverse reactionsExact identifier
rxcui: 1665046
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMA-S Medication Solutions53415af6-4072-4339-83e2-d870ae02a0e22024-08-20Warnings, Adverse reactionsExact identifier
application number: ANDA203702
ndc (package): 50090-3838-0
ndc (product): 50090-3838
rxcui: 1665005
spl id: f3d65432-050d-4e4f-8cb7-2d20d230a350
spl set id: 53415af6-4072-4339-83e2-d870ae02a0e2
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMA-S Medication Solutionsb642877e-0d36-4218-afe9-0a39f35b571d2024-03-27Warnings, Adverse reactionsExact identifier
rxcui: 1665005
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONECivica, Inc.96f3fc1e-84f4-4e9b-91ac-19a1692f227a2024-02-06Warnings, Adverse reactionsExact identifier
rxcui: 1665046
rxcui: 1665021
unii: 023Z5BR09K

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.